News

12.13.2016

DRI Director Dr. Camillo Ricordi Receives Advocacy Award

Camillo Ricordi, M.D., Director of the Diabetes Research Institute at the University of Miami Miller School of Medicine, received the World Stem Cell Summit’s Advocacy Award for being “a path-finding diabetes researcher, motivating the biomedical community to take a stand for cures.”

“I want to share this award with the Diabetes Research Institute Foundation, the Cure Alliance and all the people at the Institute working to cure diabetes and many other regenerative disease conditions,” Ricordi said as he accepted the award on December 7 during the annual Stem Cell Action Gala at the Palm Beach County Convention Center (see related story).

Ricordi pointed out the need for all industries to promote scientific achievements.

“Scientists alone cannot bring the message to the public. We need to all work together, as these topics are so important,” he said. “We need people from the media, artists, performers and communication leaders to help. Together we can make a difference.”

Ricordi is Director of the Cell Transplant Program at the Miller School of Medicine, Stacy Joy Goodman Professor of Surgery, and distinguished professor of medicine, biomedical engineering, microbiology and immunology. Acknowledged as one of the world’s leading scientists in diabetes cure-focused research and cell transplantation, he has authored more than 1,000 scientific publications. He has been awarded 25 patents, including the automated method and Ricordi Chamber used to obtain large numbers of insulin-producing cells from the human pancreas.

He is currently working on immunomodulation and stem cell strategies to reverse autoimmunity, and on biologic replacement platform technologies, like the DRI BioHub for the cure of diabetes without the need for anti-rejection drugs.

Ricordi has also devoted himself to supporting the cause of stem cell research. He is a founding member of the science advisory board of the Regenerative Medicine Foundation, and in 2004 he spoke at the organization’s seminal meeting at the United Nations headquarters. He founded and served as the first president of the Cure Alliance, whose primary goal is to promote collaborative efforts and help accelerate potential cures from the laboratory to the bedside.

The World Stem Cell Summit is the largest interdisciplinary stem cell meeting in the world, featuring more than 250 prominent scientists, business leaders, investors, philanthropists, regulators, policy-makers, economic development officers, patient advocates, and experts in law and ethics.

News Archives

Office of the Dean

A message from the dean

Med

Read Med

e-Update

Read e-Update